← Eichor
Study identifier: NCT06470607 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Lymphocytic Infiltrate of Lung Tumors.

Condition: Lung Cancer · Immune System  ·  Sponsor: Scientific Institute San Raffaele

PhaseN/A
Planned participants70
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The study is configured as a monocentric observational transversal biological study. The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC). The study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Pierluigi Novellis, MD  ·  +39022643  ·  novellis.pierluigi@hsr.it

Always discuss trial participation with your own doctor first.

Locations (1)

Scientific Institute Ospedale San RaffaeleMilan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06470607